Sung Lee
Director of Finance/CFO at VIR BIOTECHNOLOGY, INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Sung H.
Lee is currently the Chief Financial Officer, Secretary & Executive VP at Vir Biotechnology, Inc. He previously held positions as Vice President-Investor Relations at Gilead Sciences, Inc. from 2005 to 2019, Chief Financial Officer & Executive Vice President at Sangamo Therapeutics, Inc. from 2019 to 2021, and Chief Financial Officer at MorphoSys AG from 2021 to 2023.
Mr. Lee holds a graduate degree from the University of Southern California and an undergraduate degree from the University of California, Irvine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VIR BIOTECHNOLOGY, INC.
0.07% | 2024-03-26 | 100,492 ( 0.07% ) | 1 M $ | 2024-03-30 |
Sung Lee active positions
| Companies | Position | Start |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Director of Finance/CFO | 2023-03-26 |
Former positions of Sung Lee
| Companies | Position | End |
|---|---|---|
| MORPHOSYS AG | Director of Finance/CFO | 2023-03-16 |
| SANGAMO THERAPEUTICS, INC. | Director of Finance/CFO | 2021-01-31 |
| GILEAD SCIENCES, INC. | Investor Relations Contact | 2019-10-30 |
Training of Sung Lee
| University of Southern California | Graduate Degree |
| University of California, Irvine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| MORPHOSYS AG | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
- Stock Market
- Insiders
- Sung Lee
